North-West University
Overview of innovation

This invention relates to a pharmaceutical composition for parenteral or oral administration containing a radioactive compound which can be used diagnostically or therapeutically. The composition comprises a micro-emulsion consti­tuted by dispersion of vesicles or microsponges of a fatty acid-based component in an aqueous or other pharmacologically acceptable carriers in which nitrous oxide is dissolved, the fatty acid-based component comprising at least one long chain fatty acid-based substance selected from the group consisting of free fatty acids and derivatives of free fatty acids, and the radioactive compound.

The technology offers a less invasive administration of radioactive drugs and has the potential for commercialisation in the global health market.

Type of Intellectual Property protection
Innovation Opportunity Type
Human health and social work activities
Pharmaceuticals and Biopharmaceuticals
Technology Readiness Level
TRL 4 – Experimental prototype developed